74134-78-4

Basic information

• Product Name: (2R,3S)-3,4-epoxy-1,2-O-isopropylidenebutane-1,2-diol
• Synonyms: (2R,3S)-3,4-epoxy-1,2-O-isopropylidenebutane-1,2-diol
• CAS NO: 74134-78-4
• Molecular Weight: 144.17
• Mol File: 74134-78-4.mol
• Article Data: 23

Chemical Properties

• CAS DataBase Reference: (2R,3S)-3,4-epoxy-1,2-O-isopropylidenebutane-1,2-diol(CAS DataBase Reference)
• NIST Chemistry Reference: (2R,3S)-3,4-epoxy-1,2-O-isopropylidenebutane-1,2-diol(74134-78-4)
• EPA Substance Registry System: (2R,3S)-3,4-epoxy-1,2-O-isopropylidenebutane-1,2-diol(74134-78-4)

Safety Data

• Hazardous Substances Data: 74134-78-4(Hazardous Substances Data)

Upstream product

• 410095-27-1 Benzoic acid (S)-2-((S)-2,2-dimethyl-[1,3]dioxolan-4-yl)-2-methanesulfonyloxy-ethyl ester 
• 593-71-5 Chloroiodomethane 
• 15186-48-8 2,3-isopropylidene-glyceraldehyde 
• 50271-42-6 5,6-O-isopropylidene-D-isoascorbic acid 
• 132842-19-4 1,2-O-isopropylidene-3-O-(m-nitrobenzenesulfonyl)-4-O-pivaloyl-L-threitol 
• 146444-81-7 Benzoic acid (S)-2-((S)-2,2-dimethyl-[1,3]dioxolan-4-yl)-2-(toluene-4-sulfonyloxy)-ethyl ester 
• 89-65-6 isoascorbic acid 
• 128142-57-4 5,6-O-isopropylidene-2,3-di-O-methyl-D-araboascobate 
• 136136-24-8 ((4S,5R)-5-(hydroxymethyl)-2,2-dimethyl-1,3-dioxolan-4-yl)methyl butanoate 
• 136136-22-6 ((4R,5S)-5-(hydroxymethyl)-2,2-dimethyl-1,3-dioxolan-4-yl)methyl acetate 
• 161551-34-4 (S*)-S-[(4S*)(E)-2-(2,2-Dimethyl-1,3-dioxolan-4-yl)ethenyl]-N-[(4-methylphenyl)sulfonyl]-S-phenylsulfoximine 
• 135577-94-5 -3,4-<(1-methylethyliden)bis(oxy)>butandiol-4-(methylbenzolsulfonat) 
• 1774-47-6 trimethylsulfoxonium iodide 
• 161551-38-8 (2R,3R)-2-Bromo-3,4-O-isopropylidenebutane-1,3,4-triol 

Downstream Products

• 123903-53-7 (R,R)-3-O-benzyl-4-fluoro-1,2-O-isopropylidene-1,2,3-butanetriol 
• 1418112-79-4 4-chloro-6-((R)-1-((S)-2,2-dimethyl-1,3-dioxolan-4-yl)ethoxy)-2-(4-fluorobenzylthio)pyrimidine 
• 1418112-80-7 N-(6-((R)-1-((S)-2,2-dimethyl-1,3-dioxolan-4-yl)ethoxy)-2-(4-fluorobenzyl-thio)pyrimidin-4-yl)-3-methylazetidine-1-sulfonamide 
• 130550-65-1 (S)-4-((R)-1-(benzyloxy)allyl)-2,2-dimethyl-1,3-dioxolane 
• 104322-68-1 (2S)-benzyloxy-[(4S)-2,2-dimethyl-[1,3]dioxolan-4-yl]-acetaldehyde 
• 1293966-55-8 C₆₅H₁₁₁ClO₁₃Si₂ 
• 1293966-80-9 C₅₉H₉₇ClO₁₃Si 
• 1293966-66-1 C₂₀H₂₆ClNO₅ 
• 1293966-41-2 C₁₉H₂₄ClNO₅ 
• 87032-71-1 (1S)-2-amino-1-[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]ethan-1-ol 
• 103795-36-4 (3S,4R)-3-O-benzyl-4,5-O-isopropylidene-3,4,5-trihydroxypentanal 
• 128057-04-5 (3R,4S)-3-O-benzyl-4,5-O-isopropylidene-3,4,5-trihydroxypentanal 
• 98009-22-4 Ethyl (5S,6R)-5-tert-Butyldiphenylsilyloxy-6,7-O-isopropylideneheptanoate 
• 135513-76-7 (2R,3S)-4-O-allyl-3-O-benzyl-1,2-O-isopropylidenebutane-1,2,3,4-tetrol 

Relevant articles and documents

Chiral Synthesis of Natural (+)-endo-Brevicomin with Enzymatic Reaction from l-Tartaric Acid

-

Packaging comprising forms of sodium salt of 4-tert-butyl-N-[4-chloro-2-(1-oxy-pyridine-4-carbonyl)-phenyl]-benzenesulfonamide

The invention relates to a packaging comprising a multitude (A) of at least 2 administration units comprising polymorphic trihydrated forms of sodium salt of 4-tert-butyl-N-[4-chloro-2-(1-oxy-pyridine-4-carbonyl)-phenyl]-benzenesulfonamide; or (B) of at least 2 administration units comprising polymorphic solvated or desolvated forms of sodium salt of 4-tert-butyl-N-[4-chloro-2-(1-oxy-pyridine-4-carbonyl)-phenyl]-benzenesulfonamide.

CRYSTALLINE FORMS OF N-[2-[[(2,3-DIFLUOROPHENYL)METHYL]THIO]-6--4-PYRIMIDINYL]-1-AZETIDINESULFONAMIDE

There is provided crystalline forms of N-[2-[[(2,3-difluorophenyl)methyl]thio]-6-{[(1R,2S)-2,3-dihydroxy-1-methylpropyl]oxy}-4-pyrimidinyl]1-azetidinesulfon-amide anhydrate. Such compounds/forms may be useful in the treatment of a disease/condition in which modulation of chemokine receptor activity is beneficial.